Although many states and the federal government are taking a close look at granting provider status for pharmacists, the two entities have slightly different priorities.
Although many states and the federal government are taking a close look at granting provider status for pharmacists, the two entities have slightly different priorities.
ThompsonKasey Thompson, vice president, American Society of Health-System Pharmacists (ASHP), says his organization is hoping to amend the Social Security Act to grant recognition to pharmacists as providers eligible for Medicare Part B reimbursement.
Bipartisan companion bills introduced last January-the Pharmacy and Medically Underserved Areas Enhancement Act (S. 314) and H.R. 592, target that objective.
"It is about coverage of services and access to them by Medicare beneficiaries, not about a designation as provider," says Stacie Maass, senior vice president, pharmacy practice and government affairs, American Pharmacists Association.
Related: The new patient-centered pharmacy
Maass says there have been discussions on the topic for more than a decade, with more activity in recent years as states seek new ways to deliver more efficient, coordinated and team care; promote better access; and free up physician time as more individuals seek coverage under the Affordable Care Act.
Maass is optimistic that if the federal law makes it possible for pharmacists to gain reimbursement under part B, commercial insurers will follow suit in compensating pharmacists for their services. "Pharmacists have more medication expertise than anyone," she says.
Thompson says most states already consider pharmacists to be "providers," which he says is the first level of ascribing more recognition. The next level is an expanded role including such services as prescribing, furnishing immunizations and working with other healthcare team members to assess patient conditions. The highest tier is providing reimbursement for services.
"The federal legislation is important with today's insufficient number of providers and more complex medications that need special expertise," Thompson says.
Related: New weapons combat opioid addiction
By 2025, there will be a nationwide shortage of between 45,000 and 90,000 primary and specialty care physicians, according to the Association of American Medical Colleges.
If pharmacists get their way, they will join a number of non-physician practitioners who are already compensated under Part B.
NEXT: Legislation updates
States take action
States, on the other hand, are more concerned with provider designation; expanding the scope of practice of pharmacists through legislation; enabling them to offer services beyond dispensing medication; and granting pharmacist compensation by commercial and private insurers.
Related: Performance-based pharmacies improve Medicare beneficiary health
According to the National Alliance of State Pharmacy Associations, as of January, 2014, 34 states recognize pharmacists as providers, although not necessarily through legislation. Each state determines what services should correlate with the new status. The majority of states are focusing on granting status to pharmacists as a member of a healthcare team. Others have taken an additional step to increase the scope of practice and are winding their way toward reimbursement.
California passed bipartisan-sponsored legislation in 2013, effective January 1, 2014, that expanded the ability of pharmacists to collaborate with other members of a healthcare team.
Jon Roth, chief executive officer of the California Pharmacists Association, a co-sponsor of the legislation, says the law expands access to care in a community setting and appropriately uses highly-trained professionals who are underemployed.
Without provider designation under the California law, pharmacists would have difficulty accessing medical benefits and offering medical-related services, Roth says.
Based on specified requirements, California pharmacists now can directly dispense contraceptives to consumers and furnish immunizations and travel medications. In addition, with advanced practice licensing-a new category created by the law-they can:
Compensation, however, has 31 flavors, says Roth, lacking any standardization for what services pharmacists should receive payment.
NEXT: Physician response to expanded pharmacist role
Pharmacists in California and other states are signing collaborative practice agreements with physician groups and health systems and in some cases, independent community pharmacies are developing agreements with health plans, Roth says.
Dr NowakLynne Nowak, MD, senior director, clinical programs for pharmacy benefits manager at Express Scripts, is an advocate for collaborative practice agreements between pharmacists and providers as a means of helping pharmacists realize their potential.
Enabling pharmacists to practice at the top of their licenses and join other healthcare professionals in providing better care is a necessity because of an aging, sicker population, increased use of medical services, and more coverage of individuals says Nowak. "We need more providers, and many pharmacists have advanced education, licensing and training to do more than just dispense drugs," she says.
Although some physicians might be concerned about the new roles of pharmacists, Roth says pharmacists could help ensure medication safety and contribute expertise and additional services. "We are not trying to make pharmacists into surgeons or allow them to conduct physician-related services but instead, use pharmacists more effectively," he notes, adding that, when physicians work with clinical pharmacists, they begin to appreciate their expertise and ability to increase adherence and deliver care.
NEXT: Reimbursement changes
On May 11, 2015, Washington State signed into law a provision that requires commercial and private healthcare plans to enroll pharmacists into their provider networks and mandates that plans be responsible for compensating pharmacists for services rendered within their scope of practice.
Rochon"This new law should increase patient access to services by pharmacists that were not previously covered, especially in hospitals and clinics," says Jeff Rochon, chief executive officer, Washington State Pharmacy Association (WSPA).
A workgroup is expected to deliver a report on standards for credentialing, privileging, billing and payment for pharmacists to the Washington State Office of the Insurance Commissioner by December 1, 2015.
Washington was an early adopter in promoting pharmacists' role in healthcare by allowing them to prescribe, join other providers in collaborative care and manage medication therapy since 1979. The new law will add reimbursement to those and other services. "States may designate pharmacists as providers or define scope of practice enabling them to offer certain services but that doesn't necessarily mean they will receive payment for them," Rochon says.
The state also has an Every Category of Heath Care Providers Law on its books that states: "Health carriers [health insurance plans/payers] shall not exclude any category of providers licensed by the state of Washington who provide healthcare services or care within the scope of their practice..." WSPA believes pharmacists fall into one of those categories.
Rochon says that as the healthcare system evolves from fee for service to an emphasis on outcomes, pharmacists are seen as crucial to healthcare teams and should be compensated for their services.
Oregon joined California and Washington in passing a similar law on June 10, 2015. The new legislation not only establishes provider status, but also allows health insurers to pay for services provided by pharmacists through clinical pharmacy practice. In addition, it gives the Oregon Health Authority permission to work with the state board of pharmacy to establish protocols for services, such as prescribing, smoking cessation and travel medications.
Mari Edlin is a frequent contributor to Managed Healthcare Executive. She is based in Sonoma, California.
David Calabrese of OptumRx Talks New Role, Market Insulin Prices and Other Topics 'On His Mind'
April 13th 2023In this month’s episode of the "What's On Your Mind podcast," Peter Wehrwein, managing editor of MHE connects with the now Chief Clinical Officer of OptumRx Integrated Pharmacies, David Calabrese. In this conversation, David touches on his transition in January as OptumRx’s former chief pharmacy officer and market president of health plans and PBMs to his new role as Chief Clinical Officer where he now focuses more on things such as specialty pharmacy to home delivery — with an overall goal of creating whole-patient care. Throughout the conversation, Calabrese also touched on the market’s hot topic of insulin prices and behavioral health services within the OptumRx community, among other topics.
Listen
Upended: Can PBM Transparency Succeed?
March 6th 2024Simmering tensions in the pharmacy benefit management (PBM) industry have turned into fault lines. The PBMs challenging the "big three" have formed a trade association. Purchaser coalitions want change. The head of the industry's trade group says inherent marketplace friction has spilled over into political friction.
Read More
Briana Contreras, editor of Managed Healthcare Executive, spoke with Nancy Lurker, CEO and president of EyePoint Pharmaceuticals. Nancy shared a bit about EyePoint and how the organization’s innovative therapies are addressing patient needs through eye care, and most importantly, she addressed C-Suite positions like the CEO role. Nancy shared advice for those seeking to reach the CEO level, especially toward women in healthcare and other roles, and what it takes to run a biopharma company.
Listen
The deliberate disconnection of Change Healthcare to ring fence a cyberattack entered its seventh day today. Prescribers are finding ways to get pharmacy claims processed, and UnitedHealth Group says disruption to the dispensing of prescriptions has been minimal. But independent pharmacies want more information and protection from financial consequences from pharmacy benefit managers.
Read More